Drugs / salmeterol/fluticasone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00542880 | Sep 2007 → Aug 2008 | chronic obstructive pulmonary disease | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | salmeterol/fluticasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00542880 ↗ |
| Known as | Seretide Diskus | “Seretide Diskus (salmeterol/fluticasone) 50/500 μg” NCT00542880 ↗ |